Literature DB >> 14697962

Duct-to-duct biliary anastomosis for patients with sclerosing cholangitis undergoing liver transplantation.

T G Heffron1, G A Smallwood, T Ramcharan, L Davis, K Connor, E Martinez, A C Stieber.   

Abstract

BACKGROUND: Due to the association of strictures within the biliary ductal system, Roux-en-Y choledochojejunostomy has been the preferred method of anastomosis for liver transplant recipients with primary sclerosing cholangitis (PSC). The aim of this study was to evaluate duct-to-duct anastomosis in patients with PSC who undergo liver transplantation.
METHODS: Data were collected and evaluated based on demographics, type of anastomosis preformed, malignancies, outcomes comparisons, and survival.
RESULTS: Of the 60 patients transplanted for PSC, 58 were diagnosed PSC prior to transplantation and 2 were diagnosed on explant. The Roux-en-Y group (n = 38) were similar in age, gender, and race when compared to the duct-to-duct (d-d) group (n = 22). There were similar rates of anastomotic revisions when comparing d-d anastomosis with Roux-en-Y (2 [9.1%] versus 2 [5.3%], P = NS) owing to bile leaks. Based on radiologic interventions of the bile ducts, seven (18.4%) in the Roux-en-Y group had interventions compared to two (9.1%) in the duct-to-duct group (P = NS). There was also no difference in recurrence of PSC: three (7.9%) in the Roux-en-Y group compared to two (5.3%) in the duct-to-duct group (P = NS). Survival at 4 years were similar between each group (76.5% [+/- 0.07] Roux-en-Y versus 84.9% [+/- 0.08] duct-to-duct, P = NS).
CONCLUSION: Duct-to-duct anastomosis at the time of liver transplantation is both safe and efficacious when used in patients with PSC. Outcomes as described by surgical interventions, radiologic interventions, retransplantation, and survival were similar between groups.

Entities:  

Mesh:

Year:  2003        PMID: 14697962     DOI: 10.1016/j.transproceed.2003.10.035

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

Review 1.  Management of primary sclerosing cholangitis: conventions and controversies.

Authors:  Natasha Chandok; Gideon M Hirschfield
Journal:  Can J Gastroenterol       Date:  2012-05       Impact factor: 3.522

2.  Treatment of Biliary Problems in Inflammatory Bowel Disease.

Authors:  Christopher S Huang; David R Lichtenstein
Journal:  Curr Treat Options Gastroenterol       Date:  2005-04

3.  Duct-to-duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation.

Authors:  Jamak Modaresi Esfeh; Bijan Eghtesad; Peter Hodgkinson; Teresa Diago; Masato Fujiki; Koji Hashimoto; Cristiano Quintini; Federico Aucejo; Dympna Kelly; Charles Winans; David Vogt; Charles Miller; Nizar Zein; John Fung
Journal:  HPB (Oxford)       Date:  2011-07-19       Impact factor: 3.647

4.  Surgical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Florian Loehe; Rolf J Schauer
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

Review 5.  Endoscopic and surgical management of primary sclerosing cholangitis.

Authors:  Anthony Michaels; Cynthia Levy
Journal:  Medscape J Med       Date:  2008-10-21

Review 6.  End-to-end ductal anastomosis in biliary reconstruction: indications and limitations.

Authors:  Beata Jabłonska
Journal:  Can J Surg       Date:  2014-08       Impact factor: 2.089

7.  Duct-to-Duct Biliary Anastomosis Yields Similar Outcomes to Roux-en-Y Hepaticojejunostomy in Liver Transplantation for Primary Sclerosing Cholangitis.

Authors:  Bandar Al-Judaibi; Roberto Hernandez Alejandro; Julia Uhanova; Paul Marotta; Mahmoud Mosli; Natasha Chandok
Journal:  Hepat Mon       Date:  2015-05-23       Impact factor: 0.660

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.